Mobile Menu

Noxopharm Limited - Australian Company Profile

Enterprise Type: Public Company

ASX Code: NOX

What does Noxopharm Limited do?

Noxopharm is a Public Company that generates the majority of its income from the Pharmaceutical Product Manufacturing industry.

In 2024 the company generated total revenue of $0,000 including sales and other revenue. The exact number of employees for this organisation is not available.

The Chief Executive of Noxopharm is Mr Graham Kelly whose official title is MANAGING DIRECTOR & CHIEF EXECUTIVE OFFICER. The Chairman of Noxopharm is Mr Frederick Bart whose official title is Non-Executive Chair.

Noxopharm Limited - Products & Brands

Noxopharm Limited is an Australia-based, ASX-listed company, engaged in the development of the Veyonda drug. The drug can: Directly kill cancer cells Work with the body's immune system to destroy tumoursThe Company is trialling the new Veyonda product. It is currently not a registered treatment prescription medicine, however, it can be used (on compassionate grounds) for patients in Australia.

Noxopharm Limited - Key Personnel

To view Noxopharm Limited's full key personnel, see purchase options.

Noxopharm Limited - Financial Statements

Noxopharm Limited Financial Profit & Loss Account

BALANCE DATE 06/30/2024 06/30/2023 06/30/2022 06/30/2021 06/30/2020
Sales Revenue 0.0 0.0 0.0 0.0 0.0
Other Revenue
Total Revenue
Cost of Goods Sold
Depreciation
R & D Expenditure
To view all financial data for Noxopharm Limited, see purchase options.

Noxopharm Limited's Competitive Environment

Noxopharm Limited operates in the following industries:

Noxopharm Limited's main competitors:

To view all of Noxopharm Limited's operating industries and competitors, see purchase options.

Looking for IBISWorld Industry Reports?

Gain strategic insight and analysis on 700+ Australian industries
(& thousands of global industries)

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Noxopharm Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Noxopharm Limited by position type and title.

Enterprise Financials

Get a full view of Noxopharm Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Noxopharm Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Noxopharm Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Noxopharm Limited operates in.

Competitor Benchmarking

Compare Noxopharm Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Major Shareholders

We outline the ultimate parent and largest shareholders of Noxopharm Limited.

Subsidiaries

View a list of Noxopharm Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Noxopharm Limited, including founding information, past announcements, mergers and major projects.

Why buy this enterprise profile on Noxopharm Limited?

IBISWorld enterprise profiles enable you to:

  • Understand a enterprise’s competitive landscape
  • Identify industry trends a enterprise is exposed to
  • Inform your decisions for marketing, strategy and planning
  • Target key enterprise personnel

The profile on BHP Group Limited includes:

  • Enterprise History and Synopsis
  • Overview of Brands and Products
  • Enterprise Financial Statements and Financial Ratios
  • Key Enterprise Personnel
  • Subsidiaries, Shareholders and Ownership Structure
  • Service Providers

IBISWorld provides profiles on thousands of leading enterprises across Australia and New Zealand, as well as reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends. Our expert reports are thoroughly researched, reliable and current, enabling you to make faster, better business decisions.

Purchase to read full report

100% Money Back Guarantee Digicert Trusted
Download Sample Report

Included in Report

  • Enterprise History & Synopsis Enterprise History & Synopsis
  • Enterprise Financial Statements Enterprise Financial Statements
  • Financial Ratios Financial Ratios
  • Industry Averages Industry Averages
  • Competitive Landscape Competitive Landscape
  • Key Enterprise Personnel Key Enterprise Personnel
  • Subsidiaries & Ownership Structure Subsidiaries & Ownership Structure

View Top 2,000 Companies

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal